219
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test

, , , , &
Pages 231-242 | Published online: 03 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Linda Angelica Häger, Geir Øgrim, Maria Danielsen, Eva Billstedt, Christopher Gillberg & Jakob Åsberg Johnels. (2020) Indexing Executive Functions with Test Scores, Parent Ratings and ERPs: How Do the Measures Relate in Children versus Adolescents with ADHD?. Neuropsychiatric Disease and Treatment 16, pages 465-477.
Read now
Ann C. Childress. (2016) Methylphenidate HCL for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy 17:8, pages 1171-1178.
Read now

Articles from other publishers (33)

Yuji Takahara, Toyosaku Ota, Yoko Nakanishi, Shotaro Ueda, Peter Jurica, Zbignew R. Struzik, Kohei Nishitomi, Junzo Iida, Toshifumi Kishimoto, Andrzej Cichocki, Minoru Hasegawa & Koichi Ogawa. (2023) Exploration of electroencephalogram response to MPH treatment in ADHD patients. Psychiatry Research: Neuroimaging 332, pages 111631.
Crossref
Stephen V. Faraone, Roberto Gomeni, Joseph T. Hull, Soumya A. Chaturvedi, Gregory D. Busse, Zare Melyan, Welton O'Neal, Jonathan Rubin & Azmi Nasser. (2022) Predicting efficacy of viloxazine extended-release treatment in adults with ADHD using an early change in ADHD symptoms: Machine learning Post Hoc analysis of a phase 3 clinical trial. Psychiatry Research 318, pages 114922.
Crossref
Giorgia Michelini, Luke J. Norman, Philip Shaw & Sandra K. Loo. (2022) Treatment biomarkers for ADHD: Taking stock and moving forward. Translational Psychiatry 12:1.
Crossref
Wendy Verónica Herrera-Morales, Leticia Ramírez-Lugo, Roger Cauich-Kumul, Eric Murillo-Rodríguez & Luis Núñez-Jaramillo. (2022) Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it. Current Topics in Medicinal Chemistry 22:15, pages 1236-1249.
Crossref
Shun Yao, Jieying Zhu, Shuiyan Li, Ruibin Zhang, Jiubo Zhao, Xueling Yang & You Wang. (2022) Bibliometric Analysis of Quantitative Electroencephalogram Research in Neuropsychiatric Disorders From 2000 to 2021. Frontiers in Psychiatry 13.
Crossref
Anne B. Arnett, Tara M. Rutter & Mark A. Stein. (2022) Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder. Frontiers in Behavioral Neuroscience 16.
Crossref
Gráinne McLoughlin, Máté Gyurkovics & Ümit Aydin. 2022. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder 415 444 .
Pascal-M. Aggensteiner, Björn Albrecht, Ute Strehl, Sonja Wörz, Christian Ruckes, Christine M. Freitag, Aribert Rothenberger, Holger Gevensleben, Sabina Millenet, Sarah Hohmann, Tobias Banaschewski, Tanja Legenbauer, Martin Holtmann & Daniel Brandeis. (2021) Can neurophysiological markers of anticipation and attention predict ADHD severity and neurofeedback outcomes?. Biological Psychology 165, pages 108169.
Crossref
Giuseppe Augusto Chiarenza. (2020) Quantitative EEG in Childhood Attention Deficit Hyperactivity Disorder and Learning Disabilities. Clinical EEG and Neuroscience 52:2, pages 144-155.
Crossref
Virginia Peisch, Tara Rutter, Carol L. Wilkinson & Anne B. Arnett. (2021) Sensory processing and P300 event-related potential correlates of stimulant response in children with attention-deficit/hyperactivity disorder: A critical review. Clinical Neurophysiology 132:4, pages 953-966.
Crossref
Gurmukh Singh, Priti Arun, Subhash Das & Damanjeet Kaur. (2019) Can EEG Predict Response to Atomoxetine in attention deficit hyperactivity disorder at 1 Week?. Journal of Attention Disorders 25:5, pages 758-767.
Crossref
Stephen V. Faraone, Roberto Gomeni, Joseph T. Hull, Gregory D. Busse, Zare Melyan, Welton O'Neal, Jonathan Rubin & Azmi Nasser. (2021) Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trials. Psychiatry Research 296, pages 113664.
Crossref
Ping Mamiya, Anne Arnett & Mark Stein. (2021) Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition. Brain Sciences 11:1, pages 91.
Crossref
Christopher M. Barkley, Zhenhong Hu, Ann M. Fieberg, Lynn E. Eberly, Angela K. Birnbaum, Ilo E. Leppik & Susan E. Marino. (2021) An association between resting state EEG parameters and the severity of topiramate-related cognitive impairment. Epilepsy & Behavior 114, pages 107598.
Crossref
Poul Jennum, Lene Halling Hastrup, Rikke Ibsen, Jakob Kjellberg & Erik Simonsen. (2020) Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark. European Neuropsychopharmacology 37, pages 29-38.
Crossref
Anna Kaiser, Pascal-M. Aggensteiner, Sarah Baumeister, Nathalie E. Holz, Tobias Banaschewski & Daniel Brandeis. (2020) Earlier versus later cognitive event-related potentials (ERPs) in attention-deficit/hyperactivity disorder (ADHD): A meta-analysis. Neuroscience & Biobehavioral Reviews 112, pages 117-134.
Crossref
Emel Sari Gokten, Emine Elif Tulay, Birsu Beser, Mine Elagoz Yuksel, Kemal Arikan, Nevzat Tarhan & Baris Metin. (2019) Predictive Value of Slow and Fast EEG Oscillations for Methylphenidate Response in ADHD. Clinical EEG and Neuroscience 50:5, pages 332-338.
Crossref
Anna E. Kirkland & Kathleen F. Holton. (2019) Measuring Treatment Response in Pharmacological and Lifestyle Interventions Using Electroencephalography in ADHD: A Review. Clinical EEG and Neuroscience 50:4, pages 256-266.
Crossref
炎程 唐. (2019) The Mechanisms and Application of Real-Time Neurofeedback Training. Advances in Psychology 09:03, pages 486-493.
Crossref
Geir Ogrim & Juri D. Kropotov. (2018) Predicting Clinical Gains and Side Effects of Stimulant Medication in Pediatric Attention-Deficit/Hyperactivity Disorder by Combining Measures From qEEG and ERPs in a Cued GO/NOGO Task. Clinical EEG and Neuroscience 50:1, pages 34-43.
Crossref
A. Shushakova, C.D. Wiesner, P. Ohrmann & A. Pedersen. (2018) Electrophysiological evidence of an attentional bias towards appetitive and aversive words in adults with attention-deficit/hyperactivity disorder. Clinical Neurophysiology 129:9, pages 1937-1946.
Crossref
Martijn Arns, Madelon A. Vollebregt, Donna Palmer, Chris Spooner, Evian Gordon, Michael Kohn, Simon Clarke, Glen R. Elliott & Jan K. Buitelaar. (2018) Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder. European Neuropsychopharmacology 28:8, pages 881-891.
Crossref
Robabeh Soleimani, Zivar Salehi, Soheil Soltanipour, Tolou Hasandokht & Mir Mohammad Jalali. (2018) SLC6A3 polymorphism and response to methylphenidate in children with ADHD: A systematic review and meta-analysis . American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177:3, pages 287-300.
Crossref
Tatsuya Yokota, Zbigniew R. Struzik, Peter Jurica, Masahito Horiuchi, Shuichi Hiroyama, Junhua Li, Yuji Takahara, Koichi Ogawa, Kohei Nishitomi, Minoru Hasegawa & Andrzej Cichocki. (2018) Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models. Scientific Reports 8:1.
Crossref
Anne L. Høyland, Geir Øgrim, Stian Lydersen, Sigrun Hope, Morten Engstrøm, Tonje Torske, Terje Nærland & Ole A. Andreassen. (2017) Event-Related Potentials in a Cued Go-NoGo Task Associated with Executive Functions in Adolescents with Autism Spectrum Disorder; A Case-Control Study. Frontiers in Neuroscience 11.
Crossref
Ranganatha Sitaram, Tomas Ros, Luke Stoeckel, Sven Haller, Frank Scharnowski, Jarrod Lewis-Peacock, Nikolaus Weiskopf, Maria Laura Blefari, Mohit Rana, Ethan Oblak, Niels Birbaumer & James Sulzer. (2016) Closed-loop brain training: the science of neurofeedback. Nature Reviews Neuroscience 18:2, pages 86-100.
Crossref
Kerstin Mayer & Martijn Arns. (2016) Electroencephalogram Neurofeedback: Application in ADHD and Epilepsy. Psychiatric Annals 46:10, pages 594-600.
Crossref
Geir Ogrim, Ida Emilia Aasen & Jan Ferenc Brunner. (2016) Single-dose effects on the P3no-go ERP component predict clinical response to stimulants in pediatric ADHD. Clinical Neurophysiology 127:10, pages 3277-3287.
Crossref
Giuseppe Augusto Chiarenza, Robert Chabot, Robert Isenhart, Luciano Montaldi, Marco Paolo Chiarenza, Maria Grazia Lo Torto & Leslie S. Prichep. (2016) The quantified EEG characteristics of responders and non-responders to long-term treatment with atomoxetine in children with attention deficit hyperactivity disorders. International Journal of Psychophysiology 104, pages 44-52.
Crossref
Tieme W. P. Janssen, Marleen Bink, Katleen Geladé, Rosa van Mourik, Athanasios Maras & Jaap Oosterlaan. (2016) A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD. Journal of Child Psychology and Psychiatry 57:5, pages 633-644.
Crossref
. 2016. Functional Neuromarkers for Psychiatry. Functional Neuromarkers for Psychiatry 423 429 .
Agatha Lenartowicz & Sandra K. Loo. (2014) Use of EEG to Diagnose ADHD. Current Psychiatry Reports 16:11.
Crossref
Anna Esparham, Randall Evans, Leigh Wagner & Jeanne Drisko. (2014) Pediatric Integrative Medicine Approaches to Attention Deficit Hyperactivity Disorder (ADHD). Children 1:2, pages 186-207.
Crossref